NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

Under the current system, PBMs act as middlemen between manufacturers, insurers and pharmacies - inflating drug prices at the expense of patients with complex rebate and pricing structures. In ...

Drug manufacture's programs for low income ... of the Federal Trade Commission lawsuit against them for inflating insulin prices to boost their profits at the expense of vulnerable patients.

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

The Inflation Reduction Act is unlikely to generate savings for taxpayers, while disrupting the market and creating perverse ...

People with diabetes are more likely to have high cholesterol. Research suggests that insulin resistance and problems with blood sugar management can impair the way your body uses and stores fat.

Chintagunta, and IIM Ahmedabad’s Arvind Sahay. Analyzing an array of data following the introduction of a policy in India regulating prescription drug prices, the researchers find that average sales ...

The Federal Trade Commission (FTC) is asking for information from wholesalers and other middlemen in the ... “Generic prices are decreasing, drug purchasers are becoming more concentrated ...

The FDA sent the Danish drugmaker a complete response letter (CRL) declining to approve the drug, insulin icodec, saying that it needs more information on its manufacturing process, as well as ...